Research and Markets (http://www.researchandmarkets.com/research/b7299d/medical_equipment)
has announced the addition of GlobalData's new report "Medical
Equipment Monthly Deals Analysis - December 2009" to their offering.
“Medical
Equipment Monthly Deals Analysis - December 2009”
Medical
Equipment Monthly Deals Analysis - December 2009
Summary
Our Medical
Equipment Monthly Deals Analysis - December 2009 report is an
essential source of data and trend analysis on the mergers and
acquisitions and financings in the medical equipment market. The report
provides detailed information on M&A, Equity/Debt Offerings, Private
Equity, Venture Financing and Partnership transactions registered in the
medical equipment industry in November 2009. The report portrays
detailed comparative data on the number of deals and their value in the
last six months subdivided by deal types, segments, and geographies.
Additionally, the report provides information on top financial advisory
firms in the medical equipment industry.
Data presented in this report is derived from Our proprietary in-house
Medical eTrack deals database and primary and secondary research.
Scope
-
Analyze market trends for the medical equipment market in the global
arena
-
Review of deal trends in anesthesia and respiratory devices,
cardiovascular devices, dental devices, diabetes care devices,
diagnostic imaging, drug delivery devices, endoscopy devices, ENT
devices, healthcare IT, hospital supplies, in vitro diagnostics,
nephrology and urology devices, neurology devices, opthalmic devices,
patient monitoring, surgical equipment, and wound care management
segments
-
Analysis of M&A, Equity/Debt Offerings, Private Equity, Venture
Financing and Partnerships in the medical equipment market
-
Summary of medical equipment deals globally in the last six months
-
Information on the top deals that took place in the medical equipment
market
-
Geographies covered include - North America, Europe, Asia Pacific,
South & Central America, and Middle East & Africa
-
League Tables of financial advisors in M&A and equity/debt offerings.
This includes key advisors such as Morgan Stanley, Credit Suisse, and
Goldman Sachs
Reasons to buy